BE633949A - Médicament correcteur de troubles métaboliques. - Google Patents

Médicament correcteur de troubles métaboliques.

Info

Publication number
BE633949A
BE633949A BE633949A BE633949A BE633949A BE 633949 A BE633949 A BE 633949A BE 633949 A BE633949 A BE 633949A BE 633949 A BE633949 A BE 633949A BE 633949 A BE633949 A BE 633949A
Authority
BE
Belgium
Prior art keywords
corrective
medication
metabolic disorders
metabolic
disorders
Prior art date
Application number
BE633949A
Other languages
English (en)
Inventor
Jean De Larebeyrette
Original Assignee
Jean De Larebeyrette
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jean De Larebeyrette filed Critical Jean De Larebeyrette
Publication of BE633949A publication Critical patent/BE633949A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE633949A 1962-06-22 1963-06-21 Médicament correcteur de troubles métaboliques. BE633949A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR901749A FR2106M (fr) 1962-06-22 1962-06-22

Publications (1)

Publication Number Publication Date
BE633949A true BE633949A (fr) 1963-11-04

Family

ID=8781697

Family Applications (1)

Application Number Title Priority Date Filing Date
BE633949A BE633949A (fr) 1962-06-22 1963-06-21 Médicament correcteur de troubles métaboliques.

Country Status (3)

Country Link
US (1) US3183160A (fr)
BE (1) BE633949A (fr)
FR (1) FR2106M (fr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2183589A (en) * 1939-12-19 Derivatives of compounds of the
US2860149A (en) * 1954-01-11 1958-11-11 Syntex Sa Process for the saponification of 21-esters of 20-keto pregnanes
US2862939A (en) * 1954-08-12 1958-12-02 Searle & Co Esters of 2, 17, 21-trihydroxy-4-pregnene-3, 20-dione
US2801202A (en) * 1954-12-24 1957-07-30 Smith Kline French Lab Compositions containing cortisone or hydrocortisone with phenylephrine
US2793159A (en) * 1955-03-09 1957-05-21 Upjohn Co Stable hydrocortisone solution
US2928852A (en) * 1958-03-19 1960-03-15 Upjohn Co 6-methyl-17alpha, 21-dihydroxy-4, 9(11)-pregnadiene-3, 20-dione and the 21-esters thereof

Also Published As

Publication number Publication date
US3183160A (en) 1965-05-11
FR2106M (fr) 1963-11-29

Similar Documents

Publication Publication Date Title
FR1360016A (fr) Autopilote pour hydroglisseur
FR2470M (fr) Composition thérapeutique.
BE617130A (fr) Dispositif pour machines à dérouler le bois
BE633950A (fr) Médicament correcteur de troubles métaboliques.
BE633949A (fr) Médicament correcteur de troubles métaboliques.
FR2369M (fr) Nouveau médicament contre les troubles du systeme nerveux central.
DK102829C (da) Såmaskine.
FR1347M (fr) Médicament injectable pour les troubles psychiques.
DK104197C (da) Påstrygningsorgan for væsker.
FR3559M (fr) Nouvelles diamines alicycliques.
FR1984M (fr) Médicament régulateur neuropsychique.
FR2519M (fr) Médicament analgésique.
BE618277R (fr) Médicament injectable pour les troubles psychiques.
FR2098M (fr) Médicament dérivé la pipérazine.
FR1497M (fr) Nouvelle médication antalgique.
FR1328343A (fr) Casier à bouteilles perfectionné
DK98531C (da) Væskeforstøver.
BE559299A (fr) Procede d'hydrogenation.
FR35F (fr) Médicament injectable pour les troubles psychiques.
BE604579A (fr) Médicament injectable pour les troubles psychiques.
FR1828M (fr) Médicament spasmolytique.
FR2456M (fr) Médicament hémothérapique.
CA612790A (en) Multiple unit transistor circuit with means for maintaining common zone at a fixed reference potential
CA641906A (en) Supporting stirrup for tracks
FR2967M (fr) Médicament a base de nouvelle azétidine.